Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ March 28, 2023 ] Process Engineer I, MTS Technical – Kite Pharma – El Segundo, CA Los Angeles Biotech Jobs
  • [ March 28, 2023 ] BIOLASE DELIVERS 24% REVENUE GROWTH IN 2022 AS GO-TO-MARKET STRATEGIES GAIN MOMENTUM; GUIDES FOR AT LEAST 25% REVENUE GROWTH AND PROFITABILITY IN 2023 Los Angeles Biotech News
  • [ March 28, 2023 ] B. Riley Leads Financing to Support Harrow Health Acquisition Los Angeles Biotech News
  • [ March 28, 2023 ] L.A.’s Bioscience Community Mourns the Passing of SoCalBio Founder, President and CEO Ahmed Enany Los Angeles Biotech News
  • [ March 28, 2023 ] Medical Science Liaison – Los Angeles – Taylor Strategy Partners – Los Angeles, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsWatch: Blockbuster drug Humira has new competition. Here’s why that matters

Watch: Blockbuster drug Humira has new competition. Here’s why that matters

February 13, 2023 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Watch: Blockbuster drug Humira has new competition. Here’s why that matters
STAT senior writer @edsilverman breaks down the new biosimilar competition for the blockbuster drug Humira and why it matters.

Click to view original post

Previous

Dr. Steven Gundry’s Gundry MD Bio Complete 3 Celebrates Over 2 Million Units Sold in 2022

Next

Dermavant Completes Enrollment of Two Phase 3 Clinical Trials of VTAMA® (tapinarof) cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children as Young as 2 years old

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered